Dawn Carter Bir
CIK 1688712 · Interim President and CEO · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
30
Lifetime Open-Market Net
-$26.15M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GERN | Interim President and CEO | — | $1.15 | — | $0 | 9 | 2026-05-26 |
| SLNO | Director | 0 | $53.01 | $0 | $0 | 3 | 2026-05-18 |
| CASSAVA SCIENCES INC (SAVA) Delisted | Director | — | $2.34 | — | $0 | 1 | 2025-10-22 |
| REATA PHARMACEUTICALS INC (RETA) Delisted | Chief Commercial Officer | 0 | $172.36 | $0 | -$26.15M | 17 | 2023-09-26 |
Recent Filings · Page 3 of 3
30 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-06 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-10 | REATA PHARMACEUTICALS INC (RETA) Delisted | Mixed | — | -$9.75M | EDGAR |
| 2020-06-09 | GERN | Grant (A) | — | $0 | EDGAR |
| 2020-01-06 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-11-12 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-07 | GERN | Grant (A) | — | $0 | EDGAR |
| 2019-03-28 | GERN | Grant (A) | — | $0 | EDGAR |
| 2019-01-03 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-07 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-08 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–30 of 30
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.